Paragon Bioteck Drug Patent Portfolio
Paragon Bioteck owns 1 orange book drug protected by 1 US patent Given below is the list of Paragon Bioteck's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8859623 | Methods and compositions of stable phenylephrine formulations | 14 Nov, 2033 | Active |
Latest Legal Activities on Paragon Bioteck's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Paragon Bioteck.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 03 Oct, 2022 | US8859623 |
| 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity | 03 Oct, 2022 | US8859623 |
| Application Return TO OIPE | 18 Jul, 2022 | US8859623 |
|
Correspondence Address Change
Critical
| 18 Jul, 2022 | US8859623 |
| Application Return from OIPE | 18 Jul, 2022 | US8859623 |
|
Maintenance Fee Reminder Mailed
Critical
| 06 Jun, 2022 | US8859623 |
| Appeal to Court of Appeals | 13 Jan, 2017 | US8859623 |
| Termination or Final Written Decision | 14 Nov, 2016 | US8859623 |
|
Application ready for PDX access by participating foreign offices
Critical
| 31 Aug, 2015 | US8859623 |
| Petition Requesting Trial | 11 May, 2015 | US8859623 |
|
Recordation of Patent Grant Mailed
Critical
| 14 Oct, 2014 | US8859623 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 14 Oct, 2014 | US8859623 |
|
Email Notification
Critical
| 25 Sep, 2014 | US8859623 |
|
Issue Notification Mailed
Critical
| 24 Sep, 2014 | US8859623 |
| Dispatch to FDC | 15 Sep, 2014 | US8859623 |
Paragon Bioteck's Drug Patent Litigations
Paragon Bioteck's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 11, 2015, against patent number US8859623. The petitioner Altaire Pharmaceuticals, Inc., challenged the validity of this patent, with Paragon BioTeck, Inc. as the respondent. Click below to track the latest information on how companies are challenging Paragon Bioteck's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8859623 | May, 2015 |
Final Written Decision
(14 Nov, 2016)
| Paragon BioTeck, Inc. | Altaire Pharmaceuticals, Inc. |
Paragon Bioteck's Family Patents
Paragon Bioteck Drug List
Given below is the complete list of Paragon Bioteck's drugs and the patents protecting them.
1. Phenylephrine Hydrochloride
Phenylephrine Hydrochloride is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8859623 | Methods and compositions of stable phenylephrine formulations |
14 Nov, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Phenylephrine Hydrochloride's drug page